Published in J Antimicrob Chemother on May 01, 1999
Gatifloxacin activity against quinolone-resistant gyrase: allele-specific enhancement of bacteriostatic and bactericidal activities by the C-8-methoxy group. Antimicrob Agents Chemother (1999) 2.16
In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin. Antimicrob Agents Chemother (2003) 1.59
Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance. Antimicrob Agents Chemother (2001) 1.47
Activity of and resistance to moxifloxacin in Staphylococcus aureus. Antimicrob Agents Chemother (2003) 1.30
In vitro antibacterial activity and pharmacodynamics of new quinolones. Eur J Clin Microbiol Infect Dis (2003) 1.16
In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus. Antimicrob Agents Chemother (2001) 1.08
A new antibiotic with potent activity targets MscL. J Antibiot (Tokyo) (2015) 0.88
Structure based in silico analysis of quinolone resistance in clinical isolates of Salmonella Typhi from India. PLoS One (2015) 0.78
Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother (1985) 5.74
Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins. Antimicrob Agents Chemother (1983) 5.16
EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect (2011) 2.65
The negative regulator of beta-lactamase induction AmpD is a N-acetyl-anhydromuramyl-L-alanine amidase. FEMS Microbiol Lett (1994) 2.60
Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory season. Antimicrob Agents Chemother (2000) 2.57
Amikacin resistance mediated by multiresistance transposon Tn2424. J Bacteriol (1983) 2.15
Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli. Antimicrob Agents Chemother (1999) 1.99
Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis. Thorax (2009) 1.90
Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin. Antimicrob Agents Chemother (1988) 1.88
The signal molecule for beta-lactamase induction in Enterobacter cloacae is the anhydromuramyl-pentapeptide. Antimicrob Agents Chemother (1997) 1.84
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob Agents Chemother (2001) 1.74
Insertions of resistance genes into Tn21-like transposons. J Antimicrob Chemother (1986) 1.70
Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation. Antimicrob Agents Chemother (2007) 1.63
From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995 2006. Eur Respir J (2007) 1.61
HR 810, a cephalosporin with low affinity for Enterobacter cloacae beta-lactamase. Eur J Clin Microbiol (1983) 1.59
Molecular nature of a streptomycin and sulfonamide resistance plasmid (pBP1) prevalent in clinical Escherichia coli strains and integration of an ampicillin resistance transposon (TnA). Antimicrob Agents Chemother (1981) 1.58
Characterization of Tn2411 and Tn2410, two transposons derived from R-plasmid R1767 and related to Tn2603 and Tn21. J Bacteriol (1983) 1.57
[Stability of coli flora of the healthy human. 1. The occurrence of permanent and changing types]. Arch Hyg Bakteriol (1969) 1.49
Use of a broad-host-range gyrA plasmid for genetic characterization of fluoroquinolone-resistant gram-negative bacteria. Antimicrob Agents Chemother (1991) 1.42
Sequences of wild-type and mutant ampD genes of Citrobacter freundii and Enterobacter cloacae. Antimicrob Agents Chemother (1993) 1.34
Prospective evaluation of emerging bacteria in cystic fibrosis. J Cyst Fibros (2005) 1.33
Beta-lactam antibiotics and selection of resistance: speculation on the evolution of R-plasmids. J Antimicrob Chemother (1986) 1.32
Evolution of Tn21-related transposons: isolation of Tn2425, which harbours IS161. J Gen Microbiol (1985) 1.24
Genetic control of beta-lactamase production in Enterobacter cloacae. Rev Infect Dis (1988) 1.21
Tn21-specific structures in gram-negative bacteria from clinical isolates. Antimicrob Agents Chemother (1992) 1.20
Natural antibiotic susceptibility of Providencia stuartii, P. rettgeri, P. alcalifaciens and P. rustigianii strains. J Med Microbiol (1998) 1.19
Natural antibiotic susceptibility of Enterobacter amnigenus, Enterobacter cancerogenus, Enterobacter gergoviae and Enterobacter sakazakii strains. Clin Microbiol Infect (2002) 1.19
Impact of the ampD gene and its product on beta-lactamase production in Enterobacter cloacae. Rev Infect Dis (1988) 1.18
Natural antibiotic susceptibility of Listeria species: L. grayi, L. innocua, L. ivanovii, L. monocytogenes, L. seeligeri and L. welshimeri strains. Clin Microbiol Infect (2000) 1.16
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains. Antimicrob Agents Chemother (1999) 1.15
Characterization of aminoglycoside 6'-N-acetyltransferases [AAC(6')] from gram-negative bacteria and Streptomyces kanamyceticus. J Antimicrob Chemother (1985) 1.14
Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA. Antimicrob Agents Chemother (2001) 1.14
Mechanisms of quinolone resistance. Infection (1994) 1.13
[The action of ampicillin on the intestinal flora in healthy subjects]. Zentralbl Bakteriol Orig (1965) 1.11
Natural antibiotic susceptibility of Escherichia coli, Shigella, E. vulneris, and E. hermannii strains. Diagn Microbiol Infect Dis (1999) 1.10
In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus. Antimicrob Agents Chemother (2001) 1.08
Emergence of linezolid resistance in a methicillin resistant Staphylococcus aureus strain. Infection (2007) 1.08
Elimination of plasmids by new 4-quinolones. Antimicrob Agents Chemother (1985) 1.08
Mathematical corrections for bacterial loss in pharmacodynamic in vitro dilution models. Antimicrob Agents Chemother (1995) 1.07
Development of resistance in the past decade in central Europe. J Antimicrob Chemother (1986) 1.07
Natural antibiotic susceptibility of strains of Serratia marcescens and the S. liquefaciens complex: S. liquefaciens sensu stricto, S. proteamaculans and S. grimesii. Int J Antimicrob Agents (2003) 1.05
Functional and physiological characterization of the Tn21 cassette for resistance genes in Tn2426. J Gen Microbiol (1993) 1.04
The sequence and mom-transactivation function of the C gene of bacteriophage Mu. Gene (1986) 1.04
The problems of drug-resistant pathogenic bacteria. Experimental and clinical aspects of resistance determinants. Structure and recipient ability in E. Coli mutants. Ann N Y Acad Sci (1971) 1.03
Chemical characterization and biological activity of Macfadyena unguis-cati (Bignoniaceae). J Pharm Pharmacol (2000) 1.03
Location of N-acetylmuramyl-L-alanyl-D-glutamylmesodiaminopimelic acid, presumed signal molecule for beta-lactamase induction, in the bacterial cell. Antimicrob Agents Chemother (1996) 1.03
In vivo increase in resistance to ciprofloxacin in Escherichia coli associated with deletion of the C-terminal part of MarR. Antimicrob Agents Chemother (2000) 1.01
Identification and natural antibiotic susceptibility of Morganella morganii. Diagn Microbiol Infect Dis (1998) 1.00
In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi. Antimicrob Agents Chemother (2001) 0.99
Transposition of a gene encoding OXA-2 beta-lactamase. J Gen Microbiol (1983) 0.98
[The propagation of aminoglycoside transferases in gram negative bacteria]. Int J Clin Pharmacol Biopharm (1979) 0.97
Adenylylsulphate reductase from the sulphate-reducing archaeon Archaeoglobus fulgidus: cloning and characterization of the genes and comparison of the enzyme with other iron-sulphur flavoproteins. Microbiology (1994) 0.97
Natural antimicrobial susceptibility patterns and biochemical profiles of Leclercia adecarboxylata strains. Clin Microbiol Infect (2004) 0.96
Mechanisms of antibiotic resistance and their dissemination of resistance genes in the hospital environment. Infect Control (1984) 0.95
An in-vitro study of the antimicrobial susceptibilities of Yersinia enterocolitica and the definition of a database. J Antimicrob Chemother (1999) 0.95
Natural antibiotic susceptibility of Salmonella enterica strains. Int J Antimicrob Agents (2000) 0.93
[The transmission of R factors in the human intestinal flora]. Zentralbl Bakteriol Orig (1970) 0.93
The activity of cefotiam on beta-lactamase-producing bacteria in an in-vitro model. J Antimicrob Chemother (1984) 0.92
Natural antibiotic susceptibility of Rahnella aquatilis and R. aquatilis-related strains. J Chemother (2000) 0.91
Antimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model. Antimicrob Agents Chemother (1997) 0.91
Dissemination of streptomycin and sulfonamide resistance by plasmid pBP1 in Escherichia coli. Eur J Clin Microbiol (1983) 0.90
Role of penicillin-binding proteins in the initiation of the AmpC beta-lactamase expression in Enterobacter cloacae. Antimicrob Agents Chemother (2000) 0.89
Antibiotic resistance in intensive care unit areas. Infect Control (1983) 0.88
[The COMOD system. A preservative-free multidose container for eyedrops]. Klin Monbl Augenheilkd (1994) 0.88
Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose. Infection (1997) 0.87
Prevalence of resistance of aerobic gram-negative bacilli to broad-spectrum antibacterial agents: results of a multicentre study. J Antimicrob Chemother (1990) 0.87
Transfer of the chromosomal bla gene from Enterobacter cloacae to Escherichia coli by RP4::mini-Mu. J Bacteriol (1984) 0.87
[Acute pain management in proximal femoral fractures: femoral nerve block (catheter technique) vs. systemic pain therapy using a clinic internal organisation model]. Anaesthesist (2006) 0.87
Application of in-vitro models: development of resistance. J Antimicrob Chemother (1985) 0.87
Studies on the nature of plasmids arising from conjugation in the human gastro-intestinal tract. J Med Microbiol (1973) 0.87
Natural antibiotic susceptibility of Klebsiella pneumoniae, K. oxytoca, K. planticola, K. ornithinolytica and K. terrigena strains. J Med Microbiol (2001) 0.86
Inhibition of R-plasmid transfer in Escherichia coli by 4-quinolones. Antimicrob Agents Chemother (1987) 0.86
Mobilization of extrachromosomal determinants for streptomycin resistance by transferable colicinogenic factors. Ann N Y Acad Sci (1971) 0.86
The role of N-actylglucosaminyl-1,6 anhydro N-acetylmuramyl-L-alanyl-D-glutamyl-meso-diaminopimelic acid-D-alanine for the induction of beta-lactamase in Enterobacter cloacae. Zentralbl Bakteriol (1996) 0.86
The incidence and development of resistance in Staphylococcus aureus from three European countries. J Antimicrob Chemother (1984) 0.85
Flow cytometric analysis of nephroblastomas and related neoplasms. Cancer (1986) 0.85
Bacterial elimination and therapeutic effectiveness under different schedules of amoxicillin administration. Chemotherapy (1981) 0.85
The use of bacteria producing the aminoglycoside inactivating enzyme ANT-(2") in an in-vitro model. J Antimicrob Chemother (1985) 0.85
Selection of beta-lactamase producers during cephalosporin and penicillin therapy. Scand J Infect Dis Suppl (1986) 0.85
Antibacterial activity of grepafloxacin. J Antimicrob Chemother (1997) 0.84
In vitro activity of gemifloxacin and five other fluoroquinolones against defined isogenic mutants of Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother (2000) 0.84
Molecular characterisation of linezolid resistance in two vancomycin-resistant (VanB) Enterococcus faecium isolates using Pyrosequencing. Eur J Clin Microbiol Infect Dis (2008) 0.83
In vitro activity of sitafloxacin against Clostridium difficile. J Antimicrob Chemother (2001) 0.83
Natural antimicrobial susceptibilities of Plesiomonas shigelloides strains. J Antimicrob Chemother (2001) 0.83
Natural antibiotic susceptibilities of Edwardsiella tarda, E. ictaluri, and E. hoshinae. Antimicrob Agents Chemother (2001) 0.83
Expression of beta-lactamases in Yersinia enterocolitica strains of biovars 2, 4 and 5. J Med Microbiol (1999) 0.83
Antibacterial activity of lomefloxacin in a pharmacokinetic in vitro model. Antimicrob Agents Chemother (1990) 0.83
[Transmission and inhibition of extrachromosomal drug-resistance factors in the gastrointestinal flora]. Zentralbl Bakteriol Orig A (1972) 0.83
Genetic and biochemical basis of resistance of Enterobacteriaceae to beta-lactam antibiotics. J Antimicrob Chemother (1986) 0.83
Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolones. Antimicrob Agents Chemother (1999) 0.82
Beta-lactamase expression in Yersinia enterocolitica biovars 1A, 1B, and 3. J Med Microbiol (2000) 0.82
Multimerization and replication of plasmid pBP11. Plasmid (1982) 0.82
Tn3 as the molecular basis of ampicillin resistance in E. coli--an epidemiological survey. Zentralbl Bakteriol Mikrobiol Hyg A (1985) 0.82
Natural antibiotic susceptibility of strains of the Enterobacter cloacae complex. Int J Antimicrob Agents (2001) 0.81
[Rational use of oral antibiotics. Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy]. Med Monatsschr Pharm (2002) 0.81
Natural antibiotic susceptibility of Ewingella americana strains. J Chemother (2003) 0.80